Modeling in Organotin Chemistry Using NMR Restraints: A Case Study on the 9R,12S-[tBu2Sn]2O Derivative of Erythromycin A
- 23 March 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 121 (14) , 3284-3291
- https://doi.org/10.1021/ja982559t
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Tin-based antitumour drugsCoordination Chemistry Reviews, 1996
- Demonstrating Small 1H-119Sn Couplings by 1D and 2D Proton-Detected Heteronuclear Multiple-Bond-Correlation SpectroscopyJournal of Magnetic Resonance, Series A, 1993
- Structural and conformational characterization of (Z)-17-[2-(triphenylstannyl)vinyl]-4-estren-17β-ol using 2D proton detected1H-13C relay and 2D NOESY spectroscopyMagnetic Resonance in Chemistry, 1992
- In vitro effect of organotin-substituted steroids in human tumor cell linesInorganica Chimica Acta, 1992
- A general, high-yield reaction for the formation of (chloromethyl)oligosilanesOrganometallics, 1990
- The coordination chemistry of platinum anticancer drugs and related compounds with DNACoordination Chemistry Reviews, 1990
- Structural aspects of platinum anticancer drug interactions with DNAChemical Reviews, 1987
- Investigations into the antitumour activity of organotin compounds. 2. Diorganotin dihalide and dipseudohalide complexesInorganica Chimica Acta, 1984
- Possible pre-dissociation of diorganotin dihalide complexes: Relationship between antitumour activity and structureCancer Letters, 1984
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969